Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about ESALF Recent news which mentions ESALF < Previous 1 2 Next > FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval June 08, 2023 Tickers BIIB ESALF ESALY Tags ESALF General ESALY From Benzinga Medicare unveils plan for coverage of new Alzheimer’s drugs June 01, 2023 Tickers BIIB ESALF LLY Tags BIIB LLY ESALF From MarketWatch Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen May 04, 2023 Tickers BIIB ESALF ESALY LLY Tags BIIB Health Care Large Cap From Benzinga Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes! April 21, 2023 Tickers BIIB ESALF ESALY LLY Tags Health Care BIIB Large Cap From Benzinga Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer April 10, 2023 Tickers ESALF ESALY MRK Tags ESALY News Briefs From Benzinga National Institute on Aging Aims Building $300M Alzheimer's Research Database April 03, 2023 Tickers BIIB ESALF ESALY Tags General Government News From Benzinga Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug March 31, 2023 Tickers BIIB ESALF ESALY Tags Market News ESALF Benzinga From Benzinga Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments March 16, 2023 Tickers BIIB ESALF ESALY LLY Tags BIIB Health Care Large Cap From Benzinga Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity March 14, 2023 Tickers BIIB ESALF ESALY Tags Benzinga Market News Health Care From Benzinga Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment March 06, 2023 Tickers BIIB ESALF ESALY Tags Briefs News ESALY From Benzinga The 7 Best Growth Stocks to Buy for February 2023 February 06, 2023 Tickers ACLS CPRX DAR ESALF Tags NASDAQ:CPRX,OTCMKTS:ESALF,NYSE:TEVA,NASDAQ:ACLS,NYSE:NOW,NYSE:DAR,NASDAQ:ICLR,NYSE:PFGC,NASDAQ:LSCC Market News LSCC From InvestorPlace New Alzheimer’s drug shows some promise, but has big price tag February 02, 2023 Tickers BIIB ESALF Tags ESALF JP:4523 BIIB From MarketWatch FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway January 06, 2023 Tickers BIIB ESALF ESALY Tags ESALF General Movers From Benzinga Biogen's Alzheimer's Antibody Might Have A Third Death Associated With December 22, 2022 Tickers BIIB ESALF ESALY Tags BIIB Health Care Large Cap From Benzinga Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug December 20, 2022 Tickers CPRX ESALF ESALY Tags Market News Trading Ideas Benzinga From Benzinga Despite Safety Concerns, Analysts Are Bullish On Biogen's Second Alzheimer's Candidate November 30, 2022 Tickers BIIB ESALF ESALY Tags BIIB Health Care Biotech From Benzinga Open Questions On Safety Lingers After Eisai-Biogen's Detailed Lecanemab Data For Alzheimer's November 30, 2022 Tickers BIIB ESALF ESALY Tags Market News Benzinga Biotech From Benzinga Biogen's Potential Early Alzheimer's Treatment Sees Second Death Linked To It, Shares Fall November 28, 2022 Tickers BIIB ESALF ESALY Tags Trading Ideas Benzinga Market News From Benzinga One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments November 14, 2022 Tickers BIIB ESALF LLY MOR Tags JP:4523 BIIB MOR From MarketWatch Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers November 14, 2022 Tickers BIIB ESALF ESALY MOR Tags MOR General why it's moving From Benzinga Despite Advancement, Benefits From Alzheimer's Drugs May Be Limited, Say Researchers October 10, 2022 Tickers BIIB ESALF ESALY LLY Tags ESALF Top Stories ESALY From Benzinga Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’ September 28, 2022 Tickers BIIB ESALF SPX Tags BIIB JP:4523 SPX From MarketWatch Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer September 12, 2022 Tickers ESALF ESALY MRK Tags Benzinga MRK Market News From Benzinga Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate August 25, 2022 Tickers ESALF ESALY LLY RHHBF Tags ESALF RHHBF RHHVF From Benzinga Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal August 03, 2022 Tickers ESALF ESALY MRK Tags Biotech Large Cap Health Care From Benzinga The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate July 06, 2022 Tickers AMTI BIIB ESALF ESALY Tags Trading Ideas FDA IFRX From Benzinga The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves May 10, 2022 Tickers AGEN ARWR ATNX AVGR Tags RVNC BAYRY Guidance From Benzinga Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug May 10, 2022 Tickers BIIB ESALF ESALY Tags General ESALY News From Benzinga Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab March 22, 2022 Tickers BIIB ESALF ESALY Tags Benzinga Market News Phase 2 Trial From Benzinga FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer March 22, 2022 Tickers ESALF ESALY MRK Tags Biotech Health Care Market News From Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.